CellnLife Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Out of Business

CellnLife General Information

Description

Operator of a biotech company intended to extend a healthy lifespan and improve quality of life. The company's technology creates treatments for side effects and rare diseases that can occur before and after bone marrow transplants, enabling patients with healthy lives and wellness with unmet medical needs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8th floor 50, Digital-ro 33-gil
  • Guro-gu
  • Seoul, 08377
  • South Korea
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Corporate Office
  • 8th floor 50, Digital-ro 33-gil
  • Guro-gu
  • Seoul, 08377
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellnLife Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business Completed Out of Business
5. Early Stage VC (Series B) 31-May-2021 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series A) 30-Sep-2020 Completed Clinical Trials - Phase 1
3. Seed Round 19-Dec-2019 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view CellnLife’s complete valuation and funding history, request access »

CellnLife Patents

CellnLife Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022019649-A1 Anticancer composition comprising stem cell with enhanced efficacy Inactive 22-Jul-2020
WO-2022019403-A1 S-i-s culture method for producing high-efficacy stem cells Inactive 22-Jul-2020
WO-2021230678-A1 Cell engraftment promoting composition comprising stem cell having enhanced efficacy Inactive 13-May-2020
EP-3527982-A1 Method for selecting high-efficacy stem cell by using downregulation in expression or activity of socs Inactive 17-Oct-2016
EP-3527982-A4 Method for selecting high-efficacy stem cell by using downregulation in expression or activity of socs Inactive 17-Oct-2016 G01N33/5073
To view CellnLife’s complete patent history, request access »

CellnLife Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellnLife FAQs

  • When was CellnLife founded?

    CellnLife was founded in 2018.

  • Where is CellnLife headquartered?

    CellnLife is headquartered in Seoul, South Korea.

  • What is the size of CellnLife?

    CellnLife has 35 total employees.

  • What industry is CellnLife in?

    CellnLife’s primary industry is Therapeutic Devices.

  • Is CellnLife a private or public company?

    CellnLife is a Private company.

  • What is CellnLife’s current revenue?

    The current revenue for CellnLife is .

  • How much funding has CellnLife raised over time?

    CellnLife has raised $4.24M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process